换一批A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life.
第一作者：
Simon,Voss
第一单位：
Eli Lilly & Company Limited, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK.
作者：
医学主题词
老年人(Aged);乳腺疾病(Breast Diseases);双盲法(Double-Blind Method);女(雌)性(Female);激素替代疗法(Hormone Replacement Therapy);人类(Humans);中年人(Middle Aged);疼痛(Pain);病人依从(Patient Compliance);病人满意度(Patient Satisfaction);绝经后期(Postmenopause);生活质量(Quality of Life);选择性雌激素受体调节剂(Selective Estrogen Receptor Modulators);患者拒绝治疗(Treatment Refusal);血管舒张(Vasodilation)
DOI
10.1111/j.1471-0528.2002.01510.x
PMID
12197366
发布时间
2019-10-25
- 浏览18
BJOG
874-85页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
